Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia

Venclexta (venetoclax) - Roche, AbbVie

Synribo (omacetaxine mepesuccinate) - Teva

cytarabine - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42161662

B Zhang; G C Bai; J S He; J S Li; K Q Liu; Q L Li; S N Wei; X H Suo; Y C Mi; Z S Yan

May 21, 2026